NEW YORK (TheStreet) -- CHANGE IN RATINGS
numbers raised at Goldman through 2012. Company boosted its guidance. Buy rating and new $28 price target.
upgraded at Barclays to Overweight from Equal Weight. Price target surged to $35 from $28. 2010 and 2011 EPS estimates set at $1.96 and $2.23, respectively.
( AYE) downgraded at Credit Suisse to Neutral from Outperform. Price target sunk to $26 from $33. 2009 and 2010 EPS estimates set at $2.13 and $2.18, respectively.
Charles River Labs
rated new Neutral at UBS. $35 price target. Company has limited visibility.
rated new Neutral at UBS. $57 price target. Company is facing higher costs and pressure on its early-cycle businesses.
upgraded at UBS from Neutral to Buy. $36 price target. Valuation call, as industry trends are improving.
downgraded at Credit Suisse to Neutral from Outperform on less compelling outlook for the generation fleet. $37 price target. 2009 and 2010 EPS estimates lowered to $3.08 and $3.29, respectively.
reinstated at BofA/Merrill with a Neutral rating and $98 price target.
rated new Hold at Jefferies. $30 price target. Company is facing higher competition and difficult sales comparisons.
rated new Underperform at FBR. $26 price target. Valuation call.
upgraded at RBC from Outperform to Top Pick. $23 price target. Valuation call, as the company should continue to outperform its peers.
rated new Neutral at UBS. $25 price target. Stock appears fully valued, as internal investments will remain high in the near term.
STOCK COMMENTS / EPS CHANGES
price target boosted at BofA/Merrill to $32 from $28. Maintain Buy rating.
target, estimates increased at Weisel to $46 from $42. 2010 and 2011 EPS estimates improved to $1.82 and $2.18, respectively. Maintain Overweight rating.
numbers raised at FBR. Shares now seen reaching $36. Estimates also boosted, as business demand appears to have stabilized. Market Perform rating.
estimate higher at Barclays, which increased AMTD 2010 EPS estimate to $1.28, 2011 maintained at $1.60. Reiterate Overweight rating and $22 price target.
numbers lowered at FBR. Shares now seen reaching $20. Estimates also reduced, to reflect slower trading activity.
target, estimate raised at BofA/Merrill to $53 from $50. 2012 EPS estimate increased to $3.45 from $3.50. Reiterate Buy rating.
price target, estimates boosted at Thomas Weisel. Price target to $41 from $37. 2010 and 2011 EPS estimates increased to $3.05 and $3.23, respectively. Maintain Market Weight rating.
estimates, target raised at Goldman. BBY estimates were increased through 2010. Company is seeing higher sales, though margins are being squeezed. Neutral rating and new $46 price target.
cut from Conviction Sell List at Goldman. Valuation call, based on a $33 price target.
estimates raised at Barclays. It increased BRCM 2009 and 2010 EPS estimates to $1.15 and $1.70, respectively. Reiterate Overweight rating and $35 price target.
estimates, target increased at FBR. Shares of BRCM now expected to reach $37. Estimates also raised, to match the company's new guidance.
The Cheesecake Factory
price target higher at Barclays, boosted to $20 from $18. 2009 and 2010 EPS estimates maintained at $1.00 and $1.15, respectively. Equal Weight rating.
Discover Financial Services
( DFC) estimates lifted at Barclays. It raised DFC 2009 and 2010 EPS estimates to $0.17 and $0.90, respectively. Reiterate Overweight rating and $18 price target.
target higher, estimates lower at BofA/Merrill. It raised DISH price target to $24 from $21. 2009 and 2010 EPS estimates cut to $1.29 and $1.60, respectively. Maintain Neutral rating.
price target boosted at BofA/Merrill. It increased FSLR price target by 5 dollars to $140. Maintain Neutral rating.
added to Top Picks Live List at Citigroup. Stock has underperformed the sector since mid-year and should reverse that trend. INTC replaces QCOM on the list.
estimates boosted at Credit Suisse. It increased KMX 2010 and 2011 EPS estimates to $0.88 and $0.76, respectively. Maintain Underperform rating and $15 price target.
target, estimates increased at Barclays to $51 from $49. 2009 and 2010 EPS estimates raised to $2.88 and $3.10, respectively. Maintain Overweight rating.
estimates lowered at Goldman through 2011. Early closing of the SGP deal and a higher tax rate will weigh on numbers. Buy rating and $42 price target.
estimate boosted at Barclays. SYY 2010 EPS estimate raised to $1.78, 2011 introduced at $1.96. Reiterate Equal Weight rating and $26 price target.
estimate raised at Barclays. 2010 EPS estimate increased to $1.05, 2009 maintained at -$0.85. Reiterate Overweight rating and $22 price target.
price target boosted at Barclays to $70 from $55. 2009 and 2010 EPS estimates set at -$2.05 and -$0.45, respectively. Maintain Overweight rating.
This article was written by a staff member of TheStreet.com.